Cardiol Therapeutics Inc. (CRDL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.07
0.02 (1.90%)
At close: Oct 03, 2025, 3:59 PM
1.07
0.00%
Pre-market: Oct 06, 2025, 04:29 AM EDT

Cardiol Therapeutics Balance Sheet Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.58M 34.93M 59.47M 83.9M
Short-Term Investments
n/a 61.88K 61.88K 61.57K
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -0.00 -0.00
Receivables
361.62K n/a n/a 407.13K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 279.87K n/a n/a
Total Current Assets
31.67M 36.15M 61.44M 87.14M
Property-Plant & Equipment
195.59K 337.06K 295.74K 356.49K
Goodwill & Intangibles
n/a 210.36K 294.8K 379.25K
Total Long-Term Assets
195.59K 547.42K 590.54K 735.74K
Total Assets
31.86M 36.7M 62.03M 87.88M
Account Payables
6.98M 7.62M 8.35M 4.14M
Deferred Revenue
n/a n/a -8.35M -4.19M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a 238.18K 419.9K 6.66M
Total Current Liabilities
7.01M 8.3M 9.8M 11.57M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
125.52K 158.53K 22.42K 72.87K
Total Liabilities
7.14M 8.45M 9.83M 11.64M
Total Debt
158.53K 174.34K 72.87K 117.58K
Book Value
24.73M 28.25M 52.2M 76.24M
Book Value Per Share
0.35 0.44 0.84 1.76
Common Stock
179.34M 148.52M 147.55M 142.92M
Retained Earnings
-179.25M -142.58M -114.45M -83.52M
Comprehensive Income
n/a 3.52M 3.52M 4.18M
Shareholders Equity
24.73M 28.25M 52.2M 76.24M
Total Investments
n/a 61.88K 61.88K 61.57K